Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Nodule 5 Prostatic Neoplasms 5 Carcinoma, Hepatocellular 4 Thyroid Neoplasms 3 Thyroid Cancer, Papillary 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Melanoma 2 Uterine Cervical Dysplasia 1 Urinary Bladder, Neurogenic 1 Urinary Bladder Neoplasms 1 Spinal Dysraphism 1 Spinal Cord Compression 1 Recurrence 1 Prostatic Hyperplasia 1 Papillomavirus Infections 1 Papillary Thyroid Microcarcinoma 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Hypospadias 1 Hyperthyroidism 1 Gastrointestinal Neoplasms 1 Depression 1 Colorectal Neoplasms 1 Colorectal Cancer Metastatic 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 361 Trastuzumab 352 Paclitaxel 304 Docetaxel 272 Capecitabine 222 Letrozole 221 Carboplatin 185 Doxorubicin 181 Tamoxifen 157 Radiotherapy 154 Epirubicin 145 Fulvestrant 143 Anastrozole 139 Surveys and Questionnaires 133 Exercise 128 pertuzumab 113 Vinorelbine 110 Blood Specimen Collection 109 exemestane 106 palbociclib 104 Bevacizumab 104 pembrolizumab 98 Magnetic Resonance Spectroscopy 97 Albumin-Bound Paclitaxel 87 Gemcitabine 84 Drug Therapy 83 Lapatinib 78 130-nm albumin-bound paclitaxel 72 Neoadjuvant Therapy 71 Cisplatin 69

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Neoplasms × Transurethral Resection of Prostate × Clear all

NCT07483996 2026-03-19

CRYSTAL

Franciscus Gasthuis & Vlietland (Hospital)

Phase 3 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡